Vimentin antibody
GTX100619
ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityCanine, Feline, Human, Mouse, Rat
TargetVIM
Overview
- SupplierGeneTex
- Product NameVimentin antibody
- Delivery Days Customer9
- ApplicationsImmunoFluorescence, ImmunoPrecipitation, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1.14 mg/ml
- ConjugateUnconjugated
- Gene ID7431
- Target nameVIM
- Target descriptionvimentin
- Target synonymsepididymis secretory sperm binding protein; vimentin
- HostRabbit
- IsotypeIgG
- Scientific DescriptionAlong with the microfilaments (actins) and microtubules (tubulins), the intermediate filaments represent a third class of well-characterized cytoskeletal elements. The subunits display a tissue-specific pattern of expression. Desmin (MIM 125660) is the subunit specific for muscle and vimentin the subunit specific for mesenchymal tissue.[supplied by OMIM]
- ReactivityCanine, Feline, Human, Mouse, Rat
- Storage Instruction2°C to 8°C,-20°C or -80°C
- UNSPSC12352203
References
- ZIP1(+) fibroblasts protect lung cancer against chemotherapy via connexin-43 mediated intercellular Zn(2+) transfer. Ni C et al., 2022 Oct 7, Nat CommunRead more
- Young COVID-19 Patients Show a Higher Degree of Microglial Activation When Compared to Controls. Matschke J et al., 2022, Front NeurolRead more
- The down-regulation of XBP1, an unfolded protein response effector, promotes acute kidney injury to chronic kidney disease transition. Chen JH et al., 2022 Jun 28, J Biomed SciRead more
- Long Non-Coding RNA MIR31HG Promotes the Transforming Growth Factor beta-Induced Epithelial-Mesenchymal Transition in Pancreatic Ductal Adenocarcinoma Cells. Ko CC et al., 2022 Jun 12, Int J Mol SciRead more
- Vimentin immunoexpression and its prognostic activity in colon cancer among Caucasian patients. Brzozowa-Zasada M et al., 2022, Prz GastroenterolRead more
- Cooperative interaction between ERalpha and the EMT-inducer ZEB1 reprograms breast cancer cells for bone metastasis. Mohammadi Ghahhari N et al., 2022 Apr 19, Nat CommunRead more
- siRNA-induced CD44 knockdown suppresses the proliferation and invasion of colorectal cancer stem cells through inhibiting epithelial-mesenchymal transition. Zou W et al., 2022 Apr, J Cell Mol MedRead more
- Propolin G-Suppressed Epithelial-to-Mesenchymal Transition in Triple-Negative Breast Cancer Cells via Glycogen Synthase Kinase 3beta-Mediated Snail and HDAC6-Regulated Vimentin Degradation. Pai JT et al., 2022 Jan 31, Int J Mol SciRead more
- Effect of Invasion of Borrelia burgdorferi in Normal and Neoplastic Mammary Epithelial Cells. Gaur G et al., 2021 Oct 24, Antibiotics (Basel)Read more
- Detection of cancer stem cells by EMT-specific biomarker-based peptide ligands. Chen YA et al., 2021 Nov 17, Sci RepRead more